TY - JOUR
T1 - Family History in the Context of CKD
AU - CRIC Study Investigators and the CureGN Study
AU - Zanoni, Francesca
AU - Marasa, Maddalena
AU - Carlassara, Lucrezia
AU - Verbitsky, Miguel
AU - Khan, Atlas
AU - Wang, Chen
AU - Bundy, Joshua D.
AU - Canetta, Pietro A.
AU - Bomback, Andrew S.
AU - Parsa, Afshin
AU - Feldman, Harold I.
AU - Gharavi, Ali G.
AU - Kiryluk, Krzysztof
AU - Anderson, Amanda H.
AU - Appel, Lawrence J.
AU - Chen, Jing
AU - Cohen, Debbie L.
AU - Dember, Laura M.
AU - Go, Alan S.
AU - Lash, James P.
AU - Rahman, Mahboob
AU - Rao, Panduranga S.
AU - Shah, Vallabh O.
AU - Unruh, Mark L.
AU - Appel, Gerald
AU - Babayev, Revekka
AU - Batal, Ibrahim
AU - Bomback, Andrew
AU - Canetta, Pietro
AU - Chan, Brenda
AU - D'agati, Vivette Denise
AU - Dogra, Samitri
AU - Fernandez, Hilda
AU - Gaggero, Gabriele
AU - Gharavi, Ali
AU - Hines, William
AU - Husain, Syed Ali
AU - Kiryluk, Krzysztof
AU - Kudose, Satoru
AU - Lin, Fangming
AU - Kolupaeva, Victoria
AU - Marasa, Maddalena
AU - Markowitz, Glen
AU - Naarro-Torres, Mariela
AU - Rasouly, Hila Milo
AU - Mohan, Sumit
AU - Mongera, Nicola
AU - Nestor, Jordan
AU - Kaskel, Frederick
AU - Reidy, Kimberly
N1 - Publisher Copyright:
Copyright © 2025 by the American Society of Nephrology.
PY - 2025/8/1
Y1 - 2025/8/1
N2 - Background A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent family history affects outcomes among patients with CKD. In this study, we investigated the associations of family history of CKD, diabetes, and other conditions with common comorbidities and kidney disease progression among patients with CKD.MethodsWe performed an observational study of two prospective CKD cohorts, 2573 adults and children from the Cure Glomerulopathy Network and 3939 Chronic Renal Insufficiency Cohort adult participants. Self-reported first-degree family history of CKD, diabetes, and other common diseases was tested for associations with the risk of comorbidities and CKD progression using multivariable models.ResultsFamily history of common comorbid conditions was associated with higher risk of these conditions in the context of CKD, including approximately by over three-fold for diabetes (adjusted odds ratio [OR], 3.37; 95% confidence interval [CI], 2.73 to 4.15), 48% for cancer (adjusted OR, 1.48; 95% CI, 1.05 to 2.09), and 69% for cardiovascular disease (adjusted OR, 1.69; 95% CI, 1.36 to 2.10 in combined cohorts). While polygenic risk score (PRS) for CKD was associated with kidney disease progression (adjusted hazards ratio, 1.11; 95% CI, 1.06 to 1.16 in combined cohorts), family history of kidney disease was not an independent risk factor of disease progression in the context of existing CKD. By contrast, family history of diabetes was significantly associated with a higher risk of CKD progression independently of diabetes occurrence or PRS for diabetes (adjusted hazards ratio, 1.19; 95% CI, 1.05 to 1.35 in combined cohorts).ConclusionsBroad collection of family history in the context of CKD improved clinical risk stratification. Family history of diabetes was consistently associated with a higher risk of CKD progression independently of diabetes status or PRS for diabetes in both cohorts.
AB - Background A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent family history affects outcomes among patients with CKD. In this study, we investigated the associations of family history of CKD, diabetes, and other conditions with common comorbidities and kidney disease progression among patients with CKD.MethodsWe performed an observational study of two prospective CKD cohorts, 2573 adults and children from the Cure Glomerulopathy Network and 3939 Chronic Renal Insufficiency Cohort adult participants. Self-reported first-degree family history of CKD, diabetes, and other common diseases was tested for associations with the risk of comorbidities and CKD progression using multivariable models.ResultsFamily history of common comorbid conditions was associated with higher risk of these conditions in the context of CKD, including approximately by over three-fold for diabetes (adjusted odds ratio [OR], 3.37; 95% confidence interval [CI], 2.73 to 4.15), 48% for cancer (adjusted OR, 1.48; 95% CI, 1.05 to 2.09), and 69% for cardiovascular disease (adjusted OR, 1.69; 95% CI, 1.36 to 2.10 in combined cohorts). While polygenic risk score (PRS) for CKD was associated with kidney disease progression (adjusted hazards ratio, 1.11; 95% CI, 1.06 to 1.16 in combined cohorts), family history of kidney disease was not an independent risk factor of disease progression in the context of existing CKD. By contrast, family history of diabetes was significantly associated with a higher risk of CKD progression independently of diabetes occurrence or PRS for diabetes (adjusted hazards ratio, 1.19; 95% CI, 1.05 to 1.35 in combined cohorts).ConclusionsBroad collection of family history in the context of CKD improved clinical risk stratification. Family history of diabetes was consistently associated with a higher risk of CKD progression independently of diabetes status or PRS for diabetes in both cohorts.
KW - CKD
KW - epidemiology and outcomes
KW - glomerular diseases
KW - polymorphisms
KW - progression
KW - risk factors
UR - https://www.scopus.com/pages/publications/105000366744
UR - https://www.scopus.com/pages/publications/105000366744#tab=citedBy
U2 - 10.1681/ASN.0000000653
DO - 10.1681/ASN.0000000653
M3 - Article
C2 - 40067412
AN - SCOPUS:105000366744
SN - 1046-6673
VL - 36
SP - 1561
EP - 1571
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 8
ER -